Amplia Therapeutics Ltd. has released a press release.
Amplia Launches First Stage of Pivotal Narmafotinib Trial
Earlier from Amplia Therapeutics
- Amplia Therapeutics and Australia New Zealand Gynaecological Oncology Group (Anzgog) Announce Ovarian Cancer Study
- Amplia and ANZGOG announce Ovarian Cancer Study
- Accent Trial Mature Data Presented at International Conference